Netraprabha Institute Of Refractive Surgery Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 21-12-2024
- Paid Up Capital ₹ 1.32 M
as on 21-12-2024
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
as on 21-12-2024
- Satisfied Charges ₹ 3.00 M
as on 21-12-2024
- Revenue 15.26%
(FY 2022)
- Profit 38.07%
(FY 2022)
- Ebitda 62.87%
(FY 2022)
- Net Worth 46.62%
(FY 2022)
- Total Assets 36.35%
(FY 2022)
About Netraprabha Institute Of Refractive Surgery
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.32 M.
The company currently has active open charges totaling ₹7.50 M. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Milind Killedar, Sagar Jogalekar, Narayan Gangadhar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2002PTC017033
- Company No.
017033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2002
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Netraprabha Institute Of Refractive Surgery?
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Santosh Aphale | Director | 23-Jun-2002 | Current |
Milind Killedar | Director | 04-Jun-2002 | Current |
Sagar Jogalekar | Director | 04-Jun-2002 | Current |
Narayan Gangadhar | Director | 23-Jun-2002 | Current |
Rajkumar Patil | Director | 01-Jul-2010 | Current |
Yogesh Rajguru | Director | 01-Jul-2010 | Current |
Financial Performance of Netraprabha Institute Of Refractive Surgery.
Netraprabha Institute Of Refractive Surgery Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.26% increase. The company also saw a substantial improvement in profitability, with a 38.07% increase in profit. The company's net worth Soared by an impressive increase of 46.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Netraprabha Institute Of Refractive Surgery?
In 2020, Netraprabha Institute Of Refractive Surgery had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Anuradha Superspeciality Eye Hospital Ll PActive 6 years 8 months
Milind Killedar and Santosh Aphale are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Federal Bank Ltd. Creation Date: 03 Aug 2010 | ₹7.50 M | Open |
Bank Of Baroda Creation Date: 16 Jul 2002 | ₹3.00 M | Satisfied |
How Many Employees Work at Netraprabha Institute Of Refractive Surgery?
Unlock and access historical data on people associated with Netraprabha Institute Of Refractive Surgery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Netraprabha Institute Of Refractive Surgery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Netraprabha Institute Of Refractive Surgery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.